lovastatin has been researched along with Pneumonia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hopkins, RJ; Young, RP | 1 |
| Chiba, Y; Misawa, M; Sato, S | 1 |
| Bedient, TJ; Chen, DL; Ferkol, TW; Isakow, W; Kozlowski, J; Mintun, MA; Rosenbluth, DB; Schuster, DP; Thomas, B; Walter, MJ | 1 |
| Croze, R; Levy, BD; Pfeffer, MA; Planagumà, A; Rubin, G; Serhan, CN; Uddin, M | 1 |
| Bai, N; Miyata, R; Sin, DD; Van Eeden, SF; Vincent, R | 2 |
| Tasat, DR; Yakisich, JS | 1 |
| Arndt, PG; Fessler, MB; Jeyaseelan, S; Lieber, JG; Nick, JA; Worthen, GS; Young, SK | 1 |
1 trial(s) available for lovastatin and Pneumonia
| Article | Year |
|---|---|
[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.
Topics: Adult; Anticholesteremic Agents; Bronchoalveolar Lavage Fluid; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Neutrophil Activation; Pneumonia; Positron-Emission Tomography; Protein C; Radiopharmaceuticals; Recombinant Proteins; Young Adult | 2009 |
7 other study(ies) available for lovastatin and Pneumonia
| Article | Year |
|---|---|
Statins reduce lung inflammation by promoting the clearance of particulate matter from lung tissues.
Topics: Animals; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Lung; Particulate Matter; Phagocytosis; Pneumonia | 2013 |
Lovastatin inhibits antigen-induced airway eosinophilia without affecting the production of inflammatory mediators in mice.
Topics: Animals; Anti-Inflammatory Agents; Antigens; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Disease Models, Animal; Eosinophilia; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin E; Inflammation Mediators; Leukotriene B4; Lovastatin; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Pneumonia | 2009 |
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Disease; Animals; Anticholesteremic Agents; Cell Line; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Inflammation; Inflammation Mediators; Lipoxins; Lovastatin; Male; Mice; Neutrophils; Pneumonia; Respiratory Mucosa | 2010 |
Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM(10)) air pollution.
Topics: Animals; Bone Marrow Cells; Bromodeoxyuridine; Female; Interleukin-6; Lovastatin; Neutrophils; Particulate Matter; Pneumonia; Rabbits | 2012 |
Statins reduce ambient particulate matter-induced lung inflammation by promoting the clearance of particulate matter, < 10 μm from lung tissues.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Movement; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Interleukin-6; Interleukin-8; Lovastatin; Lung; Macrophages, Alveolar; Neutrophils; Particulate Matter; Phagocytosis; Pneumonia; Rabbits | 2013 |
Expanding the pleiotropic effects of statins: attenuation of air pollution-induced inflammatory response.
Topics: Animals; Female; Lovastatin; Neutrophils; Particulate Matter; Pneumonia | 2012 |
A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.
Topics: Actins; Animals; Bronchoalveolar Lavage Fluid; Cell Communication; Chemokines; Chemotaxis; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Klebsiella pneumoniae; Lipopolysaccharides; Lovastatin; Lung; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Pneumonia, Bacterial | 2005 |